Amgros 2027 1.1170.a

Summary

The tender concerns framework agreements for medicines supplied to the hospital pharmacies of the participating Danish regions, with possible resale to the Faroe Islands and Greenland. The framework agreements are non-exclusive and there is no purchase obligation. The tender is divided into two lots, and a bidder may submit a bid for one, both or all lots; awards are made separately for each lot. The notice states that there are no minimum suitability requirements. The bidder must comply with the mandatory exclusion grounds, submit the required ESPD declarations, and the winning bidder must provide supporting evidence before award. The medicines must be listed in Medicinpriser.dk and have a valid marketing authorisation for Denmark, and the supplier must hold the necessary EU/EEA manufacturing, import or wholesale authorisation.